FINANCIAL TIMES: “OXOLIFE IS ONE OF THE 20 SPANISH HEALTHCARE COMPANIES TO WATCH”

The Barcelona based, women’s fertility startup has developed a molecule, OXO-001, that enhances embryo implantation improving female fertility rates.